Histogen Inc. – NASDAQ:HSTO
Histogen stock price monthly change
Histogen stock price quarterly change
Histogen stock price yearly change
Histogen key metrics
Market Cap | 85.43K |
Enterprise value | N/A |
P/E | -0.23 |
EV/Sales | -1.03 |
EV/EBITDA | 0.37 |
Price/Sales | 0.94 |
Price/Book | 0.24 |
PEG ratio | N/A |
EPS | -3.13 |
Revenue | 19K |
EBITDA | -11.94M |
Income | -12.40M |
Revenue Q/Q | N/A |
Revenue Y/Y | -99.49% |
Profit margin | -281.8% |
Oper. margin | -282.38% |
Gross margin | 100% |
EBIT margin | -282.38% |
EBITDA margin | -62847.37% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeHistogen stock price history
Histogen stock forecast
Histogen financial statements
| Dec 2022 | 4K | -2.98M | -74675% |
|---|---|---|---|
| Mar 2023 | 5K | -3.47M | -69460% |
| Jun 2023 | 5K | -2.09M | -41840% |
| Sep 2023 | 5K | -3.85M | -77080% |
| Dec 2022 | 19073000 | 5.69M | 29.87% |
|---|---|---|---|
| Mar 2023 | 16051000 | 5.72M | 35.69% |
| Jun 2023 | 13542000 | 5.27M | 38.97% |
| Sep 2023 | 5817000 | 1.41M | 24.29% |
| Dec 2022 | -2.43M | -1K | -3K |
|---|---|---|---|
| Mar 2023 | -2.55M | 1K | -2K |
| Jun 2023 | -2.39M | 0 | -3K |
| Sep 2023 | -2.68M | 12K | -9K |
Histogen alternative data
| Aug 2023 | 7 |
|---|---|
| Sep 2023 | 7 |
| Oct 2023 | 7 |
| Nov 2023 | 7 |
| Dec 2023 | 7 |
| Jan 2024 | 7 |
| Feb 2024 | 7 |
| Mar 2024 | 7 |
| Apr 2024 | 7 |
| May 2024 | 7 |
| Jun 2024 | 7 |
| Jul 2024 | 7 |
Histogen other data
| Period | Buy | Sel |
|---|---|---|
| Dec 2020 | 10000 | 0 |
| Mar 2021 | 20000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | PASCOE RICHARD W director, officer.. | Common Stock | 20,000 | $1.14 | $22,800 | ||
Purchase | PASCOE RICHARD W director, officer.. | Common Stock | 10,000 | $1.24 | $12,390 | ||
Option | MENTO STEVEN J director | Common Stock | 65,000 | N/A | N/A | ||
Option | SPADA ALFRED P. officer: EVP, R&D and CSO | Restricted Stock Units | 31,343 | N/A | N/A | ||
Option | SPADA ALFRED P. officer: EVP, R&D and CSO | Common Stock | 31,343 | N/A | N/A | ||
Option | MARSHALL KEITH W officer: EVP, COO.. | Restricted Stock Units | 38,500 | N/A | N/A | ||
Option | MARSHALL KEITH W officer: EVP, COO.. | Restricted Stock Units | 38,500 | N/A | N/A | ||
Option | MARSHALL KEITH W officer: EVP, COO.. | Common Stock | 38,500 | N/A | N/A | ||
Option | MARSHALL KEITH W officer: EVP, COO.. | Common Stock | 38,500 | N/A | N/A | ||
Option | MENTO STEVEN J director | Restricted Stock Units | 65,000 | N/A | N/A |
-
When is Histogen's next earnings date?
Unfortunately, Histogen's (HSTO) next earnings date is currently unknown.
-
Does Histogen pay dividends?
No, Histogen does not pay dividends.
-
How much money does Histogen make?
Histogen has a market capitalization of 85.43K and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 310.12% to 3.77M US dollars.
-
What is Histogen's stock symbol?
Histogen Inc. is traded on the NASDAQ under the ticker symbol "HSTO".
-
What is Histogen's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Histogen?
Shares of Histogen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Histogen's key executives?
Histogen's management team includes the following people:
- Dr. Steven J. Mento Ph.D. Executive Chairman, Interim Pres & Chief Executive Officer(age: 73, pay: $1,310,000)
- Ms. Susan A. Knudson Executive Vice President, Chief Financial Officer & Corporation Sec.(age: 61, pay: $387,640)
- Dr. Gail K. Naughton Ph.D. Founder & Scientific Advisor(age: 69, pay: $330,600)
-
Is Histogen founder-led company?
Yes, Histogen is a company led by its founder Dr. Gail K. Naughton Ph.D..
-
How many employees does Histogen have?
As Jul 2024, Histogen employs 7 workers.
-
When Histogen went public?
Histogen Inc. is publicly traded company for more then 12 years since IPO on 25 Jul 2013.
-
What is Histogen's official website?
The official website for Histogen is histogen.com.
-
Where are Histogen's headquarters?
Histogen is headquartered at 10655 Sorrento Valley Road, San Diego, CA.
-
How can i contact Histogen?
Histogen's mailing address is 10655 Sorrento Valley Road, San Diego, CA and company can be reached via phone at 858 526 3100.
Histogen company profile:
Histogen Inc.
histogen.comNASDAQ
7
Biotechnology
Healthcare
Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. It offers HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; HST-004, a cell conditioned media solution to treat spinal disc repair; and Emricasan, an orally active pan-caspase inhibitor for the treatment of COVID-19. The company's preclinical product candidates include CTS-2090 and CTS-2096, which are selective caspase-1 inhibitors targeting inflammasome activation, as well as intervenes in a various inflammation mediated disease. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California.
San Diego, CA 92121
CIK: 0001383701
ISIN: US43358Y2028
CUSIP: 43358Y103
